GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02245126 | ADVAIR | GLAXOSMITHKLINE INC | Aerosol (Metered-Dose) | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG; FLUTICASONE PROPIONATE 125 MCG | Marketed |
| 02245127 | ADVAIR | GLAXOSMITHKLINE INC | Aerosol (Metered-Dose) | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG; FLUTICASONE PROPIONATE 250 MCG | Marketed |
| 02240835 | ADVAIR 100 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 100 MCG | Marketed |
| 02240836 | ADVAIR 250 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 250 MCG | Marketed |
| 02240837 | ADVAIR 500 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 500 MCG | Marketed |
| 02231129 | SEREVENT DISKUS (50MCG/DOSE) | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG | Marketed |
| 02211742 | SEREVENT (25MCG/ACTUATION) | GLAXOSMITHKLINE INC | Metered-Dose Aerosol | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG | Cancelled Post Market |
| 02136139 | SEREVENT- AEM 25MCG/AEM | GLAXO CANADA INC | Metered-Dose Aerosol | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG | Cancelled Post Market |
| 02136147 | SEREVENT-PWR 50MCG/BLISTER PACK | GLAXO CANADA INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG | Cancelled Post Market |